Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.
We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered.
Our breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Our in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.
Company Details
- Employees
- 57
- Founded
- -
- Address
- 30-02 48th Ave,
- Phone
- (516)847-5485
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- envisagenics.com
- Keywords
- Drug Discovery, Artificial Intelligence, Machine Learning, RNA, Splicing, AI, Deep Learning.
- HQ
- New York, NY
Envisagenics Questions
Envisagenics's helpline number is (516)847-5485
Envisagenics's website is envisagenics.com
Envisagenics's LinkedIn profile is https://www.linkedin.com/company/envisagenics
Envisagenics has
57 employees.
View email and phone details for 57
employees at Envisagenics.
Envisagenics's industry is
Biotechnology Research
Envisagenics's top competitors are
Kingdom Supercultures,
Royalty Pharma,
Biospherix, Llc,
Nuvation Bio,
Lexeo Therapeutics,
Anavex Life Sciences,
Dianthus Therapeutics, Inc.,
Immunic Therapeutics,
Protara Therapeutics,
Gilgamesh Pharmaceuticals.
Envisagenics's support email address is info@envisagenics.com
Envisagenics's categories are Biotechnology Research
Envisagenics's founding year is 2014
